Acute Lymphocytic Leukemia Clinical Trials in Chicago, Illinois
2 recruitingChicago, Illinois
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+10 more
Newave Pharmaceutical Inc100 enrolled8 locationsNCT04771572
Recruiting
Phase 1Phase 2
A Study of CTD402 in T-ALL/LBL Patients
Lymphoma, LymphoblasticAcute Lymphocytic Leukemia Refractory
BIOHENG THERAPEUTICS US LLC54 enrolled8 locationsNCT07070219